Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | transient receptor potential cation channel | 0.0161 | 0.5 | 0.5 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0161 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.5 | 0.5 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0161 | 0.5 | 0.5 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0161 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.5 | 0.5 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0161 | 0.5 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0161 | 0.5 | 0.5 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0161 | 0.5 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0161 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 30 uM | Inhibition of Mycobacterium tuberculosis TrxR after 10 mins by microplate reader analysis | ChEMBL. | 23676086 |
Inhibition (binding) | = 10.4 % | Inhibition of human TrxR at 100 uM by spectrophotometry | ChEMBL. | 23676086 |
Inhibition (binding) | = 26.7 % | Inhibition of Mycobacterium tuberculosis TrxR at 1.67 uM after 10 mins by microplate reader analysis | ChEMBL. | 23676086 |
Inhibition (binding) | = 31 % | Inhibition of Mycobacterium tuberculosis TrxR at 45 uM after 10 mins by microplate reader analysis | ChEMBL. | 23676086 |
Inhibition (binding) | = 31.7 % | Inhibition of Mycobacterium tuberculosis TrxR at 5 uM after 10 mins by microplate reader analysis | ChEMBL. | 23676086 |
Inhibition (binding) | = 43.3 % | Inhibition of Mycobacterium tuberculosis TrxR at 15 uM after 10 mins by microplate reader analysis | ChEMBL. | 23676086 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.